Open access · OA via OpenAlex

Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies

Suowen Xu, Iqra Ilyas, Peter J. Little, Hong Li, Danielle Kamato, Xueying Zheng, Sihui Luo, Zhuoming Li, Peiqing Liu, Jihong Han, Ian C. Harding, Eno E. Ebong, Scott J. Cameron, Alastair G. Stewart, Jianping Weng

Pharmacological Reviews · 2021 · ▲ 1,165 citations

Mitochondrial dysfunction

＋ Sign in to save

Abstract

This review in Pharmacological Reviews 2021 examines the role of endothelial dysfunction in atherosclerotic cardiovascular diseases and other pathologies.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1124/pharmrev.120.000096
Canonical: link ↗
Fetched: 2026-09-20 MST

Cite this

APA

Xu, S., Ilyas, I., Little, P.J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., Harding, I.C., Ebong, E.E., Cameron, S.J., Stewart, A.G., & Weng, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. <em>Pharmacological Reviews</em>. https://doi.org/10.1124/pharmrev.120.000096

Vancouver

Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological Reviews. 2021. doi:10.1124/pharmrev.120.000096.

BibTeX

@article{suowen2021Endoth, title = {Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies}, author = {Suowen Xu and Iqra Ilyas and Peter J. Little and Hong Li and Danielle Kamato and Xueying Zheng and Sihui Luo and Zhuoming Li and Peiqing Liu and Jihong Han and Ian C. Harding and Eno E. Ebong and Scott J. Cameron and Alastair G. Stewart and Jianping Weng}, journal = {Pharmacological Reviews}, year = {2021}, doi = {10.1124/pharmrev.120.000096}, }